Objective: Superoxide dismutase-2 (SOD2) is considered one of the most important antioxidant enzymes that regulate cellular redox state in normal and tumorigenic cells. Overexpression of this enzyme may be involved in carcinogenesis, particularly in lung, gastric, colorectal and breast cancer. Methods: In the present study, we have evaluated SOD2 protein levels by immunohistochemistry (IHC) in 331 cervical histological samples including 31 low-grade cervical intraepithelial neoplasia (LSIL), 51 high-grade cervical intraepithelial neoplasia (HSIL), 197 squamous cervical carcinomas (SCC) and 52 cervical adenocarcinomas (ADENO). Results: We observed that SOD2 staining increases with cervical disease severity. Intense SOD2 staining was found in 13% of LSIL, 25.5% of HSIL and 40% of SCC. Moreover, 65.4% of ADENO exhibited intense SOD2 staining. Conclusions: Differences in the expression of SOD2 could potentially be used as a biomarker for the characterization of different stages of cervical disease.
Introduction
The natural history of cervical cancer is associated with persistent infection of human papillomavirus (HPV), which is now recognized as a necessary cause for this disease. The identification of pre-invasive le-sions and associated markers of progression has an important value for screening purposes and prognostic evaluation of these lesions [7] . Cervical carcinoma and its precursor lesions are important problems of public health, carrying high annual morbidity and mortality in developing countries. Most of the available molecular tests designed to identify high risk HPV infection can significantly improve the cervical cancer screening [8, 28] . There are 2 main histological types of cervical cancer: squamous cell carcinomas (SCC) and adenocarcinomas (ADENO). Among the cervical lesions induced by HPV, ADENO are one of the most challeng-ing types to be understood and recognized in cytological daily routine examination. This difficulty is due to the scarcity of cases and some particular characteristics related to the neoplastic cells differentiation such as absence of prominent nucleoli, lack of acinar arrangement and other confounding morphological parameters that resemble high-grade squamous intraepithelial lesion (HSIL). Additionally, ADENO are difficult to be diagnosed because several benign lesions can mimic malignant and premalignant endocervical glandular lesions [24, 26] . Furthermore, certain variants of endocervical ADENO have unique biological behavior and should be considered as an individual entity, differing in terms of prognosis and therapy [38] .
In spite of substantial progress and opportunities for primary and secondary cervical cancer prevention, important queries still remain to be clarified regarding the molecular mechanisms controlling cervical cancer progression [30] . Thus, most of the current efforts in this field have been dedicated to the investigation of genes that are differentially expressed in cervical cancer when compared to their normal tissue counterparts. However, robust findings have shown that no more than a subset of these genes is associated with cancer progression and metastatic phenotype [10] . Using microarray approach we have compared the global transcription profile of normal and HPV-immortalized keratinocytes, upon TNFα treatment. Among the differentially expressed genes associated with inflammatory response we have identified superoxide dismutase-2 (SOD2) transcript [34] .
Superoxide dismutases (SOD) are metalloenzymes that act in the cellular antioxidant system and are ubiquitously expressed in prokaryotic and eukaryotic cells. These proteins protect redox sensitive cellular machinery from damage by catalyzing the disproportionation of superoxide anion to oxygen and hydrogen peroxide [18] . Three distinct isoforms of SOD have been identified and characterized in mammals: copper-zinc superoxide dismutase (encoded by the SOD1 gene), manganese superoxide dismutase (encoded by the SOD2 gene) and extracellular superoxide dismutase (encoded by the SOD3 gene). Members from the SOD family have similar functions, but features like their gene chromosome localization, protein structure, metal cofactor condition and cellular compartmentalization may differ from one to another [6, 25] . SOD2 is found exclusively in the mitochondrial matrix and is an evolutionary conserved enzyme in a variety of organisms [12] .
SOD alterations are associated with a number of diseases including arteriosclerosis, diabetes mellitus and Down syndrome [6] . Moreover, several studies have shown that SOD2 protein expression is up-regulated in cancer cells when compared to their normal counterparts, including colorectal [36] , lung [11] and gastric/esophageal cancers [12, 15, 17, 23] . However, the relationship between SOD2 expression and cervical carcinogenesis has not been addressed.
In the present study we have analyzed SOD2 expression in 331 cervical tissue samples including lowgrade squamous intraepithelial lesion (LSIL), highgrade squamous intraepithelial lesion (HSIL) and invasive carcinomas. We observed that SOD2 levels increase in SCC and in ADENO samples as compared to LSIL.
Materials and methods

Tissue samples and tissue microarray (TMA)
construction Fixed and paraffin embedded tissues were first sectioned in 3 μm sections, which were hematoxylin-eosin stained for selection of the appropriated tissue area. The correspondent selected areas of each tissue sample were then collected from the donor embedded tissues with a 1 mm gauge cylinder and transferred to a receptor block using a Manual Tissue Microarrayer (Beecher Instruments, Sun Prairie, WI, USA). TMA 5μm sections were cut from the receptor block and processed as described below.
Immunohistochemical SOD2 detection
After deparaffinization in xylene and rehydration in alcohol, antigen retrieval was performed by incubation in boiled citrate buffer pH 6.0 in a pressure cooker for 4 minutes. Endogenous peroxidase activity was inactivated with 3% hydrogen peroxide. Nonspecific avidin-binding was also blocked (DAKO, X0590, Carpinteria, CA, USA). Samples were incubated with an anti-SOD2 polyclonal antibody (Santa Cruz Biotechnology, sc-18504, Santa Cruz, CA, USA), 1:100 in 1% bovine serum albumin-phosphate buffered solution for 30 minutes at 37
• C and for 18 hours at 4
• C. The slides were then incubated for 30 minutes at 37
• C with secondary biotinylated rabbit anti-goat IgG, (Vector, BA5000, Burlingame, CA, USA) diluted 1:500, followed by incubation for 30 minutes at 37
• C with the complex streptavidin and biotinylated peroxidase (StreptABComplex/HRP Duet Mouse/Rabbit, DakoCytomation, K0492, Glostrup, Denmark), diluted 1:200. Slides were developed using 100 mg of 3,3'-diaminobenzidine tetrahydrochloride (Sigma, D-5637, St Louis, MO, USA), 6% H 2 O 2 , and dimethyl sulphoxide and counterstained with Harris' hematoxylin. Sections derived from an ovarian papillary serous adenocarcinoma were used as a positive control and were incubated in the absence or in the presence of anti-SOD2 antibody. Sections of normal cervical tissues were used as negative control.
Evaluation of tissue staining
The positive immunohistochemical reaction was evaluated considering the percentage of epithelial stained cells in each representative histopathological category (LSIL, HSIL, SCC and ADENO). The immunohistochemical reactions were performed in duplicate on sections obtained from the TMA blocks. Only tissue cores with more than 25% of cervical epithelium were analyzed. The evaluation was performed by examining the epithelium of the whole punch from each sample present in the TMA platforms under X200 magnification. As previously reported [35] , positive reactions were semi quantitatively scored as "negative/weak" (< 10% stained cells), "moderate' (10-50% stained cells) and "intense" (>50% stained cells) (Fig. 1) . Immunohistochemical evaluation was performed independently and blindly by two observers (ALF and FAS); the very few discordant results were discussed by both observers and a final score was established.
Statistical analysis
Comparisons among proportions were done using the Fisher exact test and the linear-by-linear association test was used to evaluate trends among proportions. Samples diagnosed as LSIL were used as the reference category for comparisons with HSIL, SCC and ADE-NO. For the statistical analysis, reactions were scored as less than 50% stained cells (negative to moderate expression) and more than 50% stained cells (intense expression). The 'negative or weak' (< 10% stained cells) samples in the LSIL group were very limited (n = 3), and this category was combined to the moderate (10-50% stained cells) group to provide more robust estimates. Odds Ratios (OR) and 95% confidence intervals were estimated using 2 × 2 contingency tables. All statistical analyses were done with the Statistical Package for the Social Sciences 15.0 software. Statistical significance was based on a value of p < 0.05.
Results
We have analyzed SOD2 expression in 331 cervical samples comprising 31 (9.3%) LSIL, 51 (15.4%) HSIL, 197 (59.5%) SCC and 52 (15.8%) ADENO. Overall, the TMA platforms used in this study were representative of different cervical lesions. An evaluation with hematoxylin-eosin staining revealed adequate results for the majority of specimens and only cores with more than 25% of cervical epithelium tissue were analyzed. Unfortunately, such tissues were not amenable for amplification of HPV genomes (or housekeeping genes, such as globin). Therefore, no data on HPV status is available in this study.
We observed a clear pattern where the percentage of samples exhibiting intense staining for SOD2 (> 50% positive cells) was increased in HSIL (25.5%, p = 0.262) and SCC (40%, p < 0.004), as compared to LSIL (13%) (Fig. 2 and Table 1 ). Furthermore, when we analyzed ADENO we observed that 65.4% of the specimens exhibited more than 50% of positive cell staining for SOD2 (p < 0.001) (Fig. 2) . Finally, we observed a significant positive association between high SOD2 expression level (> 50% stained cells) and the grade of cervical lesion. Intense positivity for SOD2 (> 50% stained cells) was significantly associated with SCC (OR = 4.4, CI: 1.4-13.1), when compared to LSIL group. Importantly, the association with SOD2 positivity was particularly stronger with ADENO (OR = 12.7, CI: 3.8-42.1). No significant difference in SOD2 expression was observed between the LSIL and HSIL samples in this study (OR = 2.3, CI: 0.6-7.8) ( Table 1) . Figure 3 shows a representative immunostaining for SOD2 in different cervical lesions and tumor samples exhibiting < 50% (Fig. 3a, c, e, and g ) or > 50% (Fig. 3b, d , f, and h) stained cells. SOD2 positive cells display preferentially a granular cytoplasmic staining pattern. Intensive staining in HSIL, SCC and ADENO displayed a strong cytoplasmic SOD2 staining throughout the lesion while no staining was observed in the stromal cells. However, in some cases SOD2 expression was also observed in inflammatory cells infiltrating both epithelium and stroma (Fig. 3b) . In general, normal squamous and glandular epithelial cells are negative for SOD2 staining. In some areas of normal squamous epithelium, however, we observed focal staining in the basal and/or suprabasal cell layers (data not shown).
Discussion
The role of SOD2 in cancer onset and progression is characterized by a complex net of events that underscores the multifactorial nature of this enzyme and its effects on important cellular processes such as cell proliferation, growth and differentiation. In vitro studies have demonstrated that overexpression of members of the SOD family correlates with increased cell differentiation, decreased cell growth and proliferation and, remarkably, reversion of malignant phenotype [19] .The exact functions of SOD2 and redox state in neoplasias are not completely understood. Theoretically, reduc- ing the oxidative stress by increasing SOD2 levels may prevent DNA injury and consequently cancer development. In fact, a protective role of SOD2 against tumor progression in several transformed cell lines has been reported [4, 5, 21, 27, 37, 39] . On the other hand, reduction of oxidative stress in tumor cells may preclude the accumulation of reactive oxygen species (ROS), preventing programmed cell death (PCD) or necrosis onset, favoring tumor progression [12, 25] . This view is supported by in vivo analyses that correlate SOD2 overexpression with worse prognosis in solid tumors. Several reports have shown increased SOD2 levels in many malignancies, including lung [20, 33] , colorectal [16, 36] , gastric and esophageal [13, 17] , brain [9] , oral [22] and skin carcinomas [32] , often associated with metastasis and poor prognosis. In contrast, SOD2 reduction was also observed in prostatic carcinomas when compared to normal tissues [1, 3] .
These apparent paradoxes have been attributed, in part, to the variation of malignant cells oxidative system according to each specific microenvironment [19] . Recently, it was demonstrated that intracellular oxidizing state is enhanced in breast cancer patients while the antioxidant defense mechanism is weakened. This enhanced activity is associated with the increasing severity of cancer as determined by TNM staging. However, the study of SOD2 levels in breast cancer generated conflicting results, with some data showing increased SOD2 [2] , whilst others clearly demonstrated a decrease in SOD2 levels [31] .
In this study, we examined the expression of SOD2 in a large set of cervical samples, including LSIL, HSIL, SCC and ADENO by IHC. We observed that HSIL and invasive cancer exhibited higher SOD2 levels than LSIL samples. For comparisons, the latter were chosen as reference category because the majority of LSIL has a benign evolution, represent HPV productive infections and regress spontaneously [14, 29] . The trend observed between SOD2 positivity and disease severity was statistically significant (p < 0.004).
In most LSIL, we observed no or low SOD2 expression (Fig. 3a) . On the other hand, HSIL, SCC and ADENO included in the > 50% staining category exhibited predominantly cytoplasmic granulated-like deposits in all the layers of the epithelium (Fig. 3d, f and  h) . Ongoing studies will determine whether the different patterns of SOD2 expression could be associated with HPV type or viral genome integration. This is the first study analyzing the expression of SOD2 in a large series of cervical samples. Our results show a trend between SOD2 positivity and severity of cervical disease including squamous and glandular invasive lesions. We can speculate that increased SOD2 levels in tumorigenic cells may confer an adaptive advantage favoring tumor establishment and progression. We are currently analyzing the correlation be- tween SOD2 expression, HPV DNA presence and clinical prognosis in a larger number of HPV-typed LSIL, HSIL, SCC and ADENOS samples. These data may contribute to determine the role of SOD2 in cervical cancer development, identification and progression.
